Reporting period: 2018-09-30 · Number of holdings: 1
Permira Europe III G.P. LTD disclosed 1 holdings in its latest 13F filing for the period ending 2018-09-30, with total reported value of — and a quarterly turnover rate of 0.0%.
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Recent moves
Unchanged 000000000
$0.0
Holdings Map
Top 10 holdings by weight
Full holdings list this quarter
#
Ticker
Issuer
Asset Subclass
Weight
Weight Change
Shares Change
4Q Trend
1
✓
Ikena Oncology INC
Stock-Other
—
—
—
Portfolio Performance
Not enough priced holdings yet to compute performance
Position changes disclosed by Permira Europe III G.P. LTD for the quarter ending 2018-09-30, including ticker, issuer, weight change, shares change, and action
What is Permira Europe III G.P. LTD and what type of investor is it?
Permira Europe III G.P. LTD is an investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2018-09-30), the firm manages a tracked equity portfolio valued at approximately —, spread across 1 disclosed positions.
What are Permira Europe III G.P. LTD's largest equity positions?
Based on the latest 13F filing, Permira Europe III G.P. LTD's top holdings by market value are:
1. Ikena Oncology INC — $0.0
What changes did Permira Europe III G.P. LTD make in its most recent portfolio filing?
No notable portfolio changes were recorded for Permira Europe III G.P. LTD in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Permira Europe III G.P. LTD focus on?
Sector breakdown data is not yet available for Permira Europe III G.P. LTD. Check back after the next 13F processing cycle.